PaTHway Phase 3 Trial Analysis slide image

PaTHway Phase 3 Trial Analysis

5 Hypoparathyroidism: Multiple Complications Brain fog Laryngospasm & bronchospasm Seizures Anxiety & depression Infections Heart failure Renal failure Numbness & tingling Muscle spasms Fatigue Shobak DM et. al. J Clin Endocrinol Metab. 2016 June 01;101(6):2300-2312. Arrhythmias Abnormal skeletal dynamics Abnormal tissue calcifications Pain TransCon PTH is an investigational product candidate. For investor communication only. Not for use in product promotion. Not for further distribution. ascendis pharma
View entire presentation